ALT: Leerink Initiates
Leerink Partners initiates coverage on Altimmune with an Outperform rating and a price target of $10
Leerink Partners Initiates Coverage On Altimmune with Outperform Rating, Announces Price Target of $10
Leerink Partners initiates coverage on Altimmune with an Outperform rating and a price target of $10
Leerink Partners Initiates Coverage On Altimmune with Outperform Rating, Announces Price Target of $10